Recent news on Corzide

First-Time Generic Approvals: Corzide, Cipro XR, Cortef  -  Apr 20, 2007
Medscape (subscription)...formulations for nadolol plus bendroflumethiazide combination tablets (Impax Laboratories, Inc; brand name Corzide, King Pharmaceuticals, Inc).

IMPAX Announces FDA Approval of Generic Corzide  -  Apr 3, 2007
PipelineReview.com (press release),..."This is our first approval in 2007 and we are very pleased to add generic Corzide to the growing portfolio of products our Global Pharmaceuticals division

Impax drug granted new drug status  -  Apr 4, 2007
Bizjournals.com,The Food and Drug Administration has granted final approval of a new drug application for Impax Laboratories Inc.'s generic form of Corzide,

US FDA Approves Generic Version of King Heart Drug  -  Apr 2, 2007
Reuters.uk,N: Quote, Profile , Research) drug Corzide to treat hypertension, the US Food and Drug Administration said on Monday.

US FDA Approves Generic Version of King Heart Drug  -  Apr 2, 2007
Reuters.uk,Corzide, also known as nadolol/bendroflumethiazide, is a type of beta blocker to treat hypertension -- a condition marked by unusually high blood pressure

FDA approves generic version of King heart drug  -  Apr 2, 2007
Therapeutics Daily (subscription) (press release),WASHINGTON (Reuters) - The US Food and Drug Administration said on Monday it approved the first generic version of King Pharmaceuticals Inc.'s drug Corzide

Gap shares up; worst may be over  -  Apr 11, 2007
Contra Costa Times,Impax Laboratories Inc. of Hayward announced that the US Food and Drug Administration has granted approval of its generic version of Corzide used to treat

US FDA approves generic version of King heart drug  -  Apr 2, 2007
ReutersN: Quote, Profile, Research) drug Corzide to treat hypertension. The agency, in a statement posted on it's Web site, did not say which generic drugmaker was

A Compelling Case for King Pharma  -  Feb 26, 2007
BusinessWeekOther cardiovascular drugs include Corzide for high blood pressure, Procanbid treatment for arrhythmia, and Thalitone, a diuretic.

King Pharmaceuticals Swings To Profit In Q4, Revenues Up 21% - Update  -  Feb 28, 2007
Trading Markets,...opioid painkillers, as well as intangible asset impairment charges totaling $94 million or $0.39 per share primarily related to Sonata and Corzide.

King Pharmaceuticals Reports Year-End and Fourth-Quarter 2006 ...  -  Feb 28, 2007
Genetic Engineering News (press release),...primarily due to (i) intangible asset impairment charges totaling $221 million primarily related to Sonata(R) and Corzide(R), (ii) a $189 million charge

King Pharma Gets Clubbed  Feb 28, 2006
...painkillers. King took $94.1 million in asset impairment charges for the insomnia medication Sonata and the blood pressure drug Corzide. ... - TheStreet.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional